Search Results for "Paediatric Study Teriflunomide"

15:18 EDT 24th May 2015 | BioPortfolio

Matching Channels

SERAPHIN study

SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Viruses

A virus is a small infectious agent that can replicate only inside the living cells of organisms. Virus particles (known as virions) consist of two or three parts: the genetic material made from eit...

Testicular Cancer

Testicular cancer represents only 1 per cent of all cancers in men, but it is the single biggest cause of cancer-related deaths in men aged 15-35 years in the UK. The causes of testicular cancer and...

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Matching News

Otonomy completes enrolment of paediatric patients in AuriPro clinical trial for AOMT

Clinical-stage biopharmaceutical firm Otonomy has completed enrolment of paediatric patients in a Phase II clinical trial, which will study AuriPro in paediatric patients with acute otitis media with ...

Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP

Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults

At a press conference at ASH 2014, Dr Stock presents the findings of her study which indicated that paediatric treatment regimens, which were generally higher in intensity, would be more effective on ...

Licensing deal will allow paediatric HIV drug to be used more widely

Children with HIV in developing countries will now have access to generic paediatric formulations of raltegravir following a licence agreement with Merck.

Travatan paediatric indication

Travatan (travoprost; Alcon) is now indicated for patients aged 2 months to 18 years with paediatric glaucoma or ocular hypertension, in addition to its indication as a treatment for adults with rai...

Merck and MPP partner to supply paediatric HIV drug in developing nations

US-based pharmaceutical firm Merck has entered an agreement with the Medicines Patent Pool (MPP) to provide its paediatric formulations of raltegravir to treat HIV-1 infection in infants and children ...

Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Revision: 3, Authorised

News and press releases: Promoting high quality scientific research in paediatric medicines

Registration now open for a workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) on 28 May 2015

Matching PubMed Articles

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.

A number of novel oral agents are now approved for use in relapsing multiple sclerosis (MS). Among these agents, teriflunomide has shown promise with respect to clinical efficacy and safety in relapsi...

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens.

To evaluate immune responses to neoantigen and recall antigens in healthy subjects treated with teriflunomide.

Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.

In mid-2014, subcutaneous or intramuscular interferon beta injection is the standard disease-modifying treatment for patients with relapsing-remitting multiple sclerosis, in the absence of a better al...

Study of the frequency, localisation and morphology of supernumerary teeth in 1960 Spanish non-syndromic paediatric patients.

The main objective was to study supernumerary teeth diagnosed during the routine checkups at the Paediatric Dentistry Service of Hospital de Nens, Barcelona (Spain), for four months.

META-ANALYSIS OF ADVERSE EVENTS IN RECENT RANDOMIZED CLINICAL TRIALS FOR DIMETHIL FUMARATE, GLATIRAMER ACETATE, AND TERIFLUNOMIDE FOR THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS.

Trials of dimethyl fumarate (DMF) and teriflunomide, two new oral therapies for relapsing-remitting multiple sclerosis (RRMS) were recently published [1, 2, 3]. A comparison of their safety against gl...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement